L. I. Papusha

662 total citations · 1 hit paper
33 papers, 213 citations indexed

About

L. I. Papusha is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, L. I. Papusha has authored 33 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 19 papers in Neurology and 9 papers in Molecular Biology. Recurrent topics in L. I. Papusha's work include Glioma Diagnosis and Treatment (28 papers), Neuroblastoma Research and Treatments (17 papers) and Brain Metastases and Treatment (7 papers). L. I. Papusha is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Neuroblastoma Research and Treatments (17 papers) and Brain Metastases and Treatment (7 papers). L. I. Papusha collaborates with scholars based in Russia, United States and Italy. L. I. Papusha's co-authors include Roger J. Packer, Felix Sahm, Jasper van der Lugt, Franco Locatelli, Isabelle Aerts, Kenneth J. Cohen, Jordan R. Hansford, Mark W. Russo, Uri Tabori and Darren Hargrave and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

L. I. Papusha

22 papers receiving 210 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

2023 125 citations Éric Bouffet, Jordan R. Hansford et al. New England Journal of Medicine profile →

Peers

L. I. Papusha

GENET

NEURO

PRM

Milica Skender-Gazibara Serbia

Amanda Merkelson United States

Lori Ramkissoon United States

Olga Zheludkova Russia

Andrés Morales La Madrid Spain

Macarena I. de la Fuente United States

Э. В. Кумирова Russia

Zhihong J. Wang United States

Justin M. Craig United States

Evelyn Dörner Germany

Milica Skender-Gazibara Serbia

L. I. Papusha

114 ×0.7

GENET

93 ×1.0

NEURO

59 ×0.9

24 ×0.8

PRM

33 ×1.1

Citations per year, relative to L. I. Papusha L. I. Papusha (= 1×) peers Milica Skender-Gazibara

Countries citing papers authored by L. I. Papusha

Since Specialization

Citations

This map shows the geographic impact of L. I. Papusha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. I. Papusha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. I. Papusha more than expected).

Fields of papers citing papers by L. I. Papusha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. I. Papusha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. I. Papusha. The network helps show where L. I. Papusha may publish in the future.

Co-authorship network of co-authors of L. I. Papusha

This figure shows the co-authorship network connecting the top 25 collaborators of L. I. Papusha. A scholar is included among the top collaborators of L. I. Papusha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. I. Papusha. L. I. Papusha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Papusha, L. I., et al.. (2025). Liquid biopsy for the detection of H3K27m in patients with brainstem tumors. Neurosurgical Review. 48(1). 442–442. 1 indexed citations

Papusha, L. I., et al.. (2023). Supratentorial tumor resembling anaplastic ependymoma in an adolescent. Brain Pathology. 33(2). e13137–e13137. 1 indexed citations

Bouffet, Éric, Jordan R. Hansford, Maria Luisa Garrè, et al.. (2023). Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations. New England Journal of Medicine. 389(12). 1108–1120. 125 indexed citations breakdown →

Papusha, L. I., et al.. (2023). HGG-12. INFANT HEMISPHERIC GLIOMA: CLINICAL AND MOLECULAR CHARACTERISTICS AND RESULTS OF TARGETED THERAPY. Neuro-Oncology. 25(Supplement_1). i41–i41.

Papusha, L. I., et al.. (2022). Analysis of genetic aberrations in pediatric low-grade gliomas: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Pediatric Hematology/Oncology and Immunopathology. 21(1). 12–18. 1 indexed citations

Papusha, L. I., et al.. (2022). Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis. Neuro-Oncology. 25(6). 1132–1145. 3 indexed citations

Usman, Natalia, et al.. (2022). Methodological Challenges of Digital PCR Detection of the Histone H3 K27M Somatic Variant in Cerebrospinal Fluid. Pathology & Oncology Research. 28. 1610024–1610024. 10 indexed citations

Mazerkina, Nadezhda, et al.. (2021). PEDIATRIC OPTIC PATHWAY GLIOMA: DIENCEPHALIC SYNDROME. SHILAP Revista de lepidopterología. 20(1). 34–45.

Papusha, L. I., et al.. (2021). The first experience of using MEK inhibitors for type 1 neurofibromatosis in children in the Russian Federation in a hospital for short-term treatment at the National Medical Research Center. Russian Journal of Pediatric Hematology and Oncology. 8(1). 85–92.

10.

Papusha, L. I., et al.. (2021). DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR IN CHILDREN: MR CHARACTERISTICS, CLINICAL FEATURES AND OUTCOME. FOUR CLINICAL CASES. Russian Journal of Biotherapy. 20(1). 42–55.

11.

Papusha, L. I., et al.. (2021). Choroid plexus carcinoma in children. Pediatric Hematology/Oncology and Immunopathology. 20(1). 66–74.

12.

Papusha, L. I., et al.. (2021). The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib. Neuro-Oncology Advances. 3(1). vdab022–vdab022. 9 indexed citations

13.

Papusha, L. I., et al.. (2020). Low-grade gliomas with the V600E mutation in the BRAF gene in children: clinical features and treatment options. Pediatric Hematology/Oncology and Immunopathology. 19(4). 58–65. 3 indexed citations

14.

Papusha, L. I., et al.. (2020). A case report of pilocytic astrocytoma of the brainstem. Pediatric Hematology/Oncology and Immunopathology. 19(4). 120–124. 2 indexed citations

15.

Papusha, L. I., et al.. (2020). Analysis of genetic aberrations in pediatric high-grade gliomas. SHILAP Revista de lepidopterología. 7(3). 37–47. 2 indexed citations

16.

Papusha, L. I., et al.. (2020). Choroid plexus carcinoma: review of literature. Russian Journal of Pediatric Hematology and Oncology. 7(1). 51–61. 1 indexed citations

17.

Papusha, L. I., et al.. (2019). Promises of targeted therapy for low grade gliomas in children. SHILAP Revista de lepidopterología. 6(2). 28–41. 1 indexed citations

18.

Mazerkina, Nadezhda, et al.. (2019). Optic pathway gliomas in children: prognostic factors, response assessment, role of carboplatin and vincristine chemotherapy regime. Pediatric Hematology/Oncology and Immunopathology. 18(1). 62–72. 3 indexed citations

19.

Novichkova, G. А., Michael Maschan, L. I. Papusha, et al.. (2018). Late effects after treosulfan- and busulfan-based myeloablative conditioning for allogeneic HSCT in children with malignant diseases: a comparative study. Pediatric Hematology/Oncology and Immunopathology. 17(2). 28–38.

20.

Balashov, Dmitry, et al.. (2011). Recovery of Ovarian Function and Pregnancy in a Patient With AML After Myeloablative Busulphan-based Conditioning Regimen. Journal of Pediatric Hematology/Oncology. 33(4). e154–e155. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact